Dik C. Van Gent
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Development of a rapid ex vivo tumor platform for drug response prediction in lung cancer.
Journal: NPJ precision oncology
Published: February 23, 2026
Motion-based tissue ex vivo (MOTEX) assay to assess proton and X-ray irradiation responses in head and neck squamous cell carcinoma.
Journal: Clinical and translational radiation oncology
Published: September 25, 2025
Motion based ex vivo (MOTEX) culture of breast tumor slices sustains microenvironment composition.
Journal: Neoplasia (New York, N.Y.)
Published: July 14, 2025
Development of an Ex Vivo Functional Assay for Prediction of Irradiation Related Toxicity in Healthy Oral Mucosa Tissue.
Journal: International journal of molecular sciences
Published: May 13, 2024
Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma - The Dutch approach.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 29, 2024
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.
Journal: Cancers
Published: November 24, 2023
Ex vivo radiation sensitivity assessment for individual head and neck cancer patients using deep learning-based automated nuclei and DNA damage foci detection.
Journal: Clinical and translational radiation oncology
Published: November 10, 2023
Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response.
Journal: Current protocols
Published: March 13, 2023
Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients.
Journal: NPJ breast cancer
Published: January 19, 2023
Last Updated: 09/26/2026